Publication Name	World Journal of Virology
Manuscript ID	67328
Country	Italy

Received	2021-04-21 10:22
Peer-Review Started	2021-04-21 10:25
To Make the First Decision
Return for Revision	2021-07-07 01:44
Revised	2021-07-16 21:36
Second Decision	2021-08-09 02:29
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-08-09 06:37
Articles in Press	2021-08-09 06:37
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-08-25 08:54
Typeset the Manuscript	2021-11-16 03:06
Publish the Manuscript Online	2021-11-22 09:40

ISSN	2220-3249 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Hematology
Manuscript Type	Minireviews
Article Title	COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review
Manuscript Source	Invited Manuscript
All Author List	Valentina Bonuomo, Isacco Ferrarini, Michele Dell'Eva, Eugenio Sbisà, Mauro Krampera and Carlo Visco
Funding Agency and Grant Number
Corresponding Author	Carlo Visco, MD, Professor, Section of Haematology, Department of Medicine, University of Verona, P. Le L.A. Scuro 10 Verona, Italy. , Verona 37134, Italy. carlo.visco@univr.it
Key Words	Lymphoma; SARS-CoV-2 infection; Haematological malignancies; COVID-19; Rituximab; Bendamustine
Core Tip	The scientific literature in the last year has been widely occupied by reports on severe acute respiratory syndrome coronavirus 2 infection. However, patients with cancer have been under-represented, and among them, patients with lymphoma have rarely been described separately. Indeed, the real impact of this tremendous pandemics on the life expectancy of patients with different subtypes of lymphoma is still unknown, especially in relation to chemo-, chemo-immunotherapy, and/or biologic treatments. Furthermore, the relationship between lymphoma patients’ characteristics and the infection behaviour is undescribed. With this review we pointed out what literature clarifies in the prognosis and management of patients with lymphoma during the coronavirus disease 2019 pandemics.
Publish Date	2021-11-22 09:40
Citation	Bonuomo V, Ferrarini I, Dell'Eva M, Sbisà E, Krampera M, Visco C. COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review. World J Virol 2021; 10(6): 312-325
URL	https://www.wjgnet.com/1007-9327/full/v27/i43/312.htm
DOI	https://dx.doi.org/10.5501/wjv.v10.i6.312

Full Article (PDF)	WJV-10-312.pdf
Full Article (Word)	WJV-10-312.docx
Manuscript File	67328-Review-FilipodiaCL.docx
Answering Reviewers	67328-Answering reviewers.pdf
Audio Core Tip	67328-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	67328-Conflict-of-interest statement.pdf
Copyright License Agreement	67328-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	67328-Language certificate.pdf
Peer-review Report	67328-Peer-review(s).pdf
Scientific Misconduct Check	67328-Scientific misconduct check.pdf
Scientific Editor Work List	67328-Scientific editor work list.pdf